Amsterdam - Delayed Quote EUR

Vivoryon Therapeutics N.V. (VVY.AS)

Compare
2.3900 +0.0300 (+1.27%)
At close: October 18 at 5:35 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue -1.81M
Earnings -8.81M
?

Analyst Price Targets

1.00
17.10 Average
2.3900 Current
60.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----33
Avg. Estimate 00-1.01-0.75
Low Estimate 00-1.1-0.82
High Estimate 00-0.88-0.63
Year Ago EPS -----1.12-1.01

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----33
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales -----3.62M--
Sales Growth (year/est) --------

Earnings History

CURRENCY IN USD
EPS Est. --
EPS Actual --
Difference --
Surprise % --

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate 00-1.01-0.75
7 Days Ago 00-0.97-0.72
30 Days Ago 00-0.97-0.72
60 Days Ago 00-0.79-0.67
90 Days Ago 00-0.8-0.93

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days ----1--
Up Last 30 Days ----1--
Down Last 7 Days --------
Down Last 30 Days ------1

Growth Estimates

CURRENCY IN USD VVY.ASIndustrySectorS&P 500
Current Qtr. ------3.70%
Next Qtr. ------7.90%
Current Year 9.80%----2.50%
Next Year 25.70%----13.10%
Next 5 Years (per annum) ------11.88%
Past 5 Years (per annum) --------

Related Tickers